Pipeline analysis from sales calls.
Diagnose why deals stall across your open pipeline — missing champion, weak business case, internal blocker, or competitive displacement — from what’s actually said on the calls, not from the CRM stage.
The CRM stage tells you where. The calls tell you why.
Pipeline analysis from sales calls means running a consistent diagnostic across every open deal — is there a champion, is the business case quantified, has a competitor entered, what is blocking progress — and rolling the answers up into a deal-risk view of the whole pipeline.
Forecasts built on CRM stages inherit rep optimism. A diagnostic anchored in the actual conversations surfaces the deals quietly going sideways while there’s still time to do something about them.
Questions a pipeline analysis can answer.
- 01Which open deals show signs of stalling, and why?
- 02Where is a champion missing or an economic buyer never engaged?
- 03Which deals lack a quantified business case this late in the cycle?
- 04Where has a competitor quietly entered the evaluation?
- 05Which deals are blocked on procurement, legal, or security?
- 06How do stall reasons differ by segment, stage, or deal size?
A real deal-risk pattern report.
Stall reasons across a quarter of open deals, ranked by frequency and segmented by where they show up.
- 0131% of open enterprise deals have no confirmed economic buyer after the second call.
- 02Deals without a quantified ROI case by week 3 are the slowest to progress.
- 03A competitor entered the evaluation in 18% of deals — usually surfaced by the buyer, not flagged by the rep.
- 04Procurement and security reviews stall mid-market deals most often in weeks 4–6.
- 05The most common silent deal-killer is an unaddressed status-quo bias, not price.
Go deeper.
Frequently asked.
How do you do pipeline analysis from sales calls?
Run a programmable call analysis across your open-pipeline cohort that asks, per deal: is there a champion and an economic buyer, is the business case quantified, has a competitor entered, and what is blocking progress. Aggregating across the pipeline surfaces the deals at risk and the reason each one is stalling.
What does pipeline analysis tell me that a CRM stage doesn't?
A CRM stage tells you where a deal sits; it can't tell you why it's stuck. Pipeline analysis reads the actual conversations to diagnose the cause — missing champion, weak business case, internal blocker, or competitive displacement — so forecast risk is grounded in evidence, not rep optimism.
Can I run pipeline analysis on a recurring schedule?
Yes. Schedule it weekly across the open pipeline and the digest lands before your pipeline review, so deal-risk signals show up while there's still time to act on them rather than in the post-mortem.
How is this different from manager deal reviews?
A deal review covers the handful of deals a manager has time to inspect. Pipeline analysis applies the same diagnostic to every open deal, so the at-risk deals surface themselves instead of waiting to be noticed.
See which deals are quietly going sideways.
100 calls free, 30 days, no credit card — enough to diagnose the deal-risk patterns across your open pipeline.
No credit card required for the 30-day trial · Most first reports back before the next stand-up